On April 6, 2026, four insiders at Vor Biopharma Inc. (VOR) collectively sold shares valued at approximately $35.51 million. The transactions included sales by Capital Healthcare Fund Lp Ra, Capital Management, L.P. Ra, Peter Kolchinsky, and Rajeev M. Shah, with each selling 537,754 shares at a price of $16.51 per share, amounting to roughly $8.88 million for each transaction.
These sales occurred on the same day and involved significant holdings. While insider selling can be attributed to various reasons such as portfolio diversification, tax obligations, or personal financial needs, coordinated sales by multiple insiders can sometimes attract investor attention.
Vor Biopharma is a clinical-stage biopharmaceutical company focused on developing cell therapies for cancer. The company's pipeline includes treatments targeting various hematological malignancies.